Jaffer Ajani
Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

Anca Ansink
Erasmus MC Daniel den Hoed Cancer Center, Rotterdam, The Netherlands

Ferran Ariza
Iberoamerican Cochrane Centre, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain

Wendy Atkin
Cancer Research UK Colorectal Cancer Unit, St Mark's Hospital, Harrow, UK

Jim Barber
Velindre NHS Trust, Cardiff, UK

Veronique Bataille
Twin Research Genetic Epidemiology Unit, St Thomas' Hospital, London, UK

Fiona Bath
Centre for Evidence-based Dermatology, Queen's Medical Centre, Nottingham, UK

MJ van den Bent
Department of Neuro-Oncology, Dr. Daniel den Hoed Cancer Center, Rotterdam, The Netherlands

William C Black
Department of Radiology, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA

Xavier Bonfill
Iberoamerican Cochrane Centre, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain

Michael Brada
Neuro-oncology Unit and Academic Unit of Radiotherapy & Oncology, The Institute of Cancer Research and the Royal Marsden NHS Trust, Sutton, UK

Vivien Bramwell
Tom Baker Cancer Centre, and University of Calgary, Calgary, Canada

D Brinkmann
Gynaecology Oncology Unit, Bart's and The London Queen Mary's School of Medicine and Dentistry, London, UK

Kathryn Burgon
Cochrane Unit, Velindre NHS Trust, Whitchurch, Cardiff, UK

Ian Chau
Gastrointestinal Unit, Department of Medicine, Royal Marsden Hospital, Sutton, UK

Chris Coppin
Medical Oncology, British Columbia Cancer Agency Fraser Valley Centre, Surrey, Canada

ER Copson
Cancer Research UK Medical Oncology Unit, The Royal South Hants Hospital, Southampton, UK

Thomas Crosby
Velindre Hospital, Whitechurch, Cardiff, UK

David Cunningham
Gastrointestinal Unit, Department of Medicine, Royal Marsden Hospital, Sutton, UK

Jack Cuzick
Imperial Cancer Research Fund Cancer Research UK, London, UK

RJ Davies
Department of General Surgery, Addenbrooke's Hospital, Cambridge, UK

Lena van Doorn
University Hospital Utrecht, Utrecht, The Netherlands

Stephen W Duffy
Queen Mary University of London, London, UK

Simon Everett
Department of Gastroenterology, Leeds General Infirmary, Leeds, UK

Richard M Fagerstrom
Biometry Research Group, National Cancer Institute, Bethesda, Maryland, USA

Rebecca L Faulkner
Academic Unit of Obstetrics and Gynaecology and Reproductive Health Care, St Mary's Hospital, Manchester, UK

John F Forbes
Department of Surgical Oncology, Newcastle Mater Hospital, University of Newcastle, NSW, Australia

David Forman
Unit of Epidemiology and Health Services Research, Medical School, University of Leeds, Leeds, UK

Paula Ghaneh
Department of Surgery, University of Liverpool, Liverpool, UK

Julie Glanville
NHS Centre for Reviews & Dissemination, University of York, UK

John K Gohagan
Early Detection Research Group, National Cancer Institute, Bethesda, Maryland, USA

Robin Grant
Department of Clinical Neurosciences, University of Edinburgh, UK

David Guthrie
Derbyshire Royal Infirmary, Derby, UK

Santosh G Honavar
Ocular Oncology Service, LV Prasad Eye Institute, Hyderabad, India

TJ Iveson
Cancer Research UK Medical Oncology Unit, The Royal South Hants Hospital, Southampton, UK

Ian Jacobs
Unit of Epidemiology and Health Services Research, Medical School, University of Leeds, Leeds, UK

Philip J Johnson
Division of Cancer Studies, School of Medicine, University of Birmingham, Birmingham, UK

Katharine Johnston
Health Economics Research Centre, Institute of Health Sciences, University of Oxford, UK

Henry C Kitchener
Academic Unit of Obstetrics and Gynaecology and Reproductive Health Care, St Mary's Hospital, Manchester, UK

Barnett S Kramer
Disease Prevention, National Institutes of Health, Bethesda, Maryland, USA

Julia Kumpf
Clinical Economics Group, University Hospital Ulm, Germany

Howard Kynaston
Department of Urology, University Hospital of Wales, Cardiff, UK

Tim Lancaster
Cochrane Tobacco Addiction Review Group, Institute of Health Sciences, Oxford, UK

Nannette J Liégeois
Department of Dermatology, Harvard Medical School, Lahey Clinic, Burlington, MA, USA

Imogen Locke
Department of Radiotherapy and Oncology, Royal Marsden Hospital, Sutton, UK

Conor Magee
Department of Surgery, University of Liverpool, Liverpool, UK

Pamela M Marcus
Biometry Research Group, National Cancer Institute, Bethesda, Maryland, USA

Malcolm Mason
Department of Clinical Oncology, Velindre NHS Trust, Whitechurch, Cardiff, UK

Miquel Mateu
Thoracic Surgery Service, Hospital Mutua de Terrassa, Barcelona, Spain

Jane Melia
Cancer Screening Evaluation Unit, Institute of Cancer Research, Sutton, UK

Usha Menon
Gynaecology Oncology Unit, Bart's and The London Queen Mary's School of Medicine and Dentistry, London, UK

M Michael
Division of Haematology and Medical Oncology, Peter MacCallum Cancer Institute, Victoria, Australia

R Miller
Department of General Surgery, Addenbrooke's Hospital, Cambridge, UK

Kate Misso
NHS Centre for Reviews and Dissemination, University of York, UK

Paul Moayyedi
Gastroenterology and Health Services Research, University of Birmingham, UK

Sue Moss
Cancer Screening Evaluation Unit, Institute of Cancer Research, Sutton, UK

John P Neoptolemos
Department of Surgery, University of Liverpool, Liverpool, UK

Alan Neville
McMaster University, Hamilton, Canada

ES Newlands
Charing Cross Hospitals, London, UK

Suzanne Olbricht
Department of Dermatology, Harvard Medical School, Lahey Clinic, Burlington, MA, USA

Tim Oliver
Medical Oncology Department, Royal Hospital NHS Trust, St Bartholomews Hospital, London, UK

William Perkins
Consultant Dermatologist and Dermatologic Surgeon, University Hospital, Queen's Medical Centre, Nottingham, UK

Alexandria Phan
Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

Paul F Pinsky
Early Detection Research Group, National Cancer Institute, Bethesda, Maryland, USA

Ernst Pöppel
Institute of Medical Psychology and Human Studies Center, Ludwig Maximilians University Munich, Germany

Franz Porzsolt
Clinical Economics Group, University Hospital Ulm, and Evidence Based Health Care, Human Studies Center, Ludwig Maximilians University Munich, Germany

Philip C Prorok
Biometry Research Group, National Cancer Institute, Bethesda, Maryland, USA

Ramón Rami-Porta
Thoracic Surgery Service, Hospital Mutua de Terrassa, Barcelona, Spain

Ian G Rennie
Department of Ophthalmology and Orthoptics, University of Sheffield, Sheffield, UK

Dafydd Roberts
Department of Dermatology, Singleton Hospital, Swansea, UK

Trevor Roberts
Northern Centre for cancer Treatment, Newcastle General Hospital, Newcastle-upon-Tyne, UK

Paul A Rundle
Department of Ophthalmology and Orthoptics, Royal Hallamshire Hospital, Sheffield, UK

Peter Sasieni
Cancer Research UK, Department of Epidemiology, Mathematics and Statistics, Wolfson Institute of Preventive Medicine, London, UK

John H Scholefield
Division of GI Surgery, University Hospital, Nottingham, UK

Mireia Serra
Thoracic Surgery Service, Hospital Mutua de Terrassa, Barcelona, Spain

Mike Shelley
Cochrane Prostatic Diseases and Urological Cancers Group, Cochrane Unit, Research Department, Velindre NHS Trust, Cardiff, UK

Peter Simmonds
Cancer Research UK Oncology Unit, Southampton General Hospital, UK

Arun D Singh
Wills Eye Hospital, Oncology Service, Philadelphia, USA

Steven Skates
Department of Medicine, Harvard Medical School and Massachusetts General Hospital, Boston, USA

Margaret F Spittle
Meyerstein Institute of Oncology, Middlesex Hospital, London, UK

Lesley Stewart
Meta-Analysis Group, MRC Clinical Trials Unit, London, UK

RP Symonds
University of Leicester, Leicester Royal Infirmary, Leicester, UK

Elinor Thompson
Iberoamerican Cochrane Centre, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain

Paul A Vasey
Cancer Research UK Department of Medical Oncology, University of Glasgow, Glasgow, UK

Jacobus van der Velden
Academic Medical Center, Amsterdam, The Netherlands

Charles J Vecht
Neuro-oncology Unit, Department of Neurology, Medical Center, The Hague, The Netherlands

Shail Verma
Ottawa Regional Cancer Centre, Ottawa, Canada

Rosalynne Weston
Focus Freelance Writing and Research, Salisbury, and Cochrane Cancer Network, Oxford, UK

Sean Whittaker
St John's Institute of Dermatology, Guy's and St Thomas' Hospital, London, UK

IR Whittle
University of Edinburgh, Edinburgh, UK

Nicholas Wilcken
Department of Medical Oncology, Westmead Hospital, Westmead, Australia

Chris Williams
Cochrane Cancer Network, Institute of Health Sciences, Oxford, UK

Hywel C Williams
Centre of Evidence-Based Dermatology, University of Nottingham, UK

JR Zalcberg
Division of Haematology and Medical Oncology, Peter MacCallum Cancer Institute, Victoria, Australia